Arcturus Therapeutics Holdings (ARCT) Enterprise Value (2018 - 2025)
Historic Enterprise Value for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to -$235.4 million.
- Arcturus Therapeutics Holdings' Enterprise Value rose 1944.64% to -$235.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$235.4 million, marking a year-over-year increase of 1944.64%. This contributed to the annual value of -$292.0 million for FY2024, which is 1629.8% up from last year.
- Latest data reveals that Arcturus Therapeutics Holdings reported Enterprise Value of -$235.4 million as of Q3 2025, which was up 1944.64% from -$251.5 million recorded in Q2 2025.
- Arcturus Therapeutics Holdings' 5-year Enterprise Value high stood at -$235.4 million for Q3 2025, and its period low was -$466.8 million during Q1 2021.
- In the last 5 years, Arcturus Therapeutics Holdings' Enterprise Value had a median value of -$319.7 million in 2022 and averaged -$327.1 million.
- In the last 5 years, Arcturus Therapeutics Holdings' Enterprise Value plummeted by 68498.6% in 2021 and then soared by 4257.37% in 2022.
- Quarter analysis of 5 years shows Arcturus Therapeutics Holdings' Enterprise Value stood at -$370.5 million in 2021, then dropped by 5.77% to -$391.9 million in 2022, then rose by 10.97% to -$348.9 million in 2023, then rose by 16.3% to -$292.0 million in 2024, then grew by 19.4% to -$235.4 million in 2025.
- Its Enterprise Value was -$235.4 million in Q3 2025, compared to -$251.5 million in Q2 2025 and -$255.4 million in Q1 2025.